Arcus Biosciences Statistics
Total Valuation
RCUS has a market cap or net worth of $2.64 billion. The enterprise value is $1.93 billion.
Important Dates
The next confirmed earnings date is Wednesday, February 25, 2026, after market close.
| Earnings Date | Feb 25, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
RCUS has 123.73 million shares outstanding. The number of shares has increased by 17.06% in one year.
| Current Share Class | 123.73M |
| Shares Outstanding | 123.73M |
| Shares Change (YoY) | +17.06% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 3.62% |
| Owned by Institutions (%) | 60.24% |
| Float | 87.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.96 |
| Forward PS | 26.48 |
| PB Ratio | 5.25 |
| P/TBV Ratio | 6.06 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.06 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.65, with a Debt / Equity ratio of 0.30.
| Current Ratio | 3.65 |
| Quick Ratio | 3.60 |
| Debt / Equity | 0.30 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -46.88 |
Financial Efficiency
Return on equity (ROE) is -68.13% and return on invested capital (ROIC) is -38.68%.
| Return on Equity (ROE) | -68.13% |
| Return on Assets (ROA) | -21.06% |
| Return on Invested Capital (ROIC) | -38.68% |
| Return on Capital Employed (ROCE) | -50.74% |
| Weighted Average Cost of Capital (WACC) | 8.69% |
| Revenue Per Employee | $382,775 |
| Profits Per Employee | -$543,860 |
| Employee Count | 627 |
| Asset Turnover | 0.22 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, RCUS has paid $1.00 million in taxes.
| Income Tax | 1.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +71.57% in the last 52 weeks. The beta is 0.84, so RCUS's price volatility has been lower than the market average.
| Beta (5Y) | 0.84 |
| 52-Week Price Change | +71.57% |
| 50-Day Moving Average | 22.75 |
| 200-Day Moving Average | 14.87 |
| Relative Strength Index (RSI) | 47.58 |
| Average Volume (20 Days) | 937,201 |
Short Selling Information
The latest short interest is 8.90 million, so 7.20% of the outstanding shares have been sold short.
| Short Interest | 8.90M |
| Short Previous Month | 7.83M |
| Short % of Shares Out | 7.20% |
| Short % of Float | 10.23% |
| Short Ratio (days to cover) | 4.84 |
Income Statement
In the last 12 months, RCUS had revenue of $240.00 million and -$341.00 million in losses. Loss per share was -$3.39.
| Revenue | 240.00M |
| Gross Profit | -263.00M |
| Operating Income | -375.00M |
| Pretax Income | -340.00M |
| Net Income | -341.00M |
| EBITDA | -365.00M |
| EBIT | -375.00M |
| Loss Per Share | -$3.39 |
Full Income StatementBalance Sheet
The company has $831.00 million in cash and $132.00 million in debt, with a net cash position of $709.00 million or $5.73 per share.
| Cash & Cash Equivalents | 831.00M |
| Total Debt | 132.00M |
| Net Cash | 709.00M |
| Net Cash Per Share | $5.73 |
| Equity (Book Value) | 436.00M |
| Book Value Per Share | 4.07 |
| Working Capital | 622.00M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$462.00 million and capital expenditures -$2.00 million, giving a free cash flow of -$464.00 million.
| Operating Cash Flow | -462.00M |
| Capital Expenditures | -2.00M |
| Free Cash Flow | -464.00M |
| FCF Per Share | -$3.75 |
Full Cash Flow StatementMargins
Gross margin is -109.58%, with operating and profit margins of -156.25% and -142.08%.
| Gross Margin | -109.58% |
| Operating Margin | -156.25% |
| Pretax Margin | -141.67% |
| Profit Margin | -142.08% |
| EBITDA Margin | -152.08% |
| EBIT Margin | -156.25% |
| FCF Margin | n/a |
Dividends & Yields
RCUS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -17.06% |
| Shareholder Yield | -17.06% |
| Earnings Yield | -12.90% |
| FCF Yield | -17.56% |
Analyst Forecast
The average price target for RCUS is $28.89, which is 35.25% higher than the current price. The consensus rating is "Buy".
| Price Target | $28.89 |
| Price Target Difference | 35.25% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 21.06% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
RCUS has an Altman Z-Score of -0.95 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.95 |
| Piotroski F-Score | 1 |
